Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 8, 2010, Pages 1091-1094

  Nemr, Rita ^a   Salman, Rabha A ^b   Jawad, Lamees H ^c   Juma, Eman A ^c   Keleshian, Sose H ^d   Almawi, Wassim Y ^c,d  

^a RIZK HOSPITAL   (Lebanon)

^b Ministry of Health Bahrain   (Bahrain)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

^d HAIGAZIAN UNIVERSITY   (Lebanon)

Author keywords

diabetic nephropathy; homocysteine; methy lenetetrahydrofolate reductase; type 2 diabetes

Indexed keywords

ALBUMIN; HOMOCYSTEINE; METHYLENETETRAHYDROFOLIC ACID;

ADULT; AGED; ALLELE; ARAB; ARTICLE; BACTERIAL GENE; COMMUNITY; CONCENTRATION (PARAMETERS); DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; URINALYSIS;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; ARABS; BAHRAIN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOCYSTEINE; HUMANS; LEBANON; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77955444027     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.228     Document Type: Article

References (22)

1. Sofi F, Lari B, Rogolino A, Marcucci R, Pratesi G, Dorigo W, et. al. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg 2005;41:255-260
2. Chango A, Boisson F, Barbe F, Quilliot D, Droesch S, Pfister M, et. al. The effect of 677C™T and 1298A™C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 2000;83:593-596
3. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et. al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113
4. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, et. al. A common mutation A1298C in human methylenetetra-hydrofolate reductase gene: association with plasma total homocysteine and folate concentration. J Nutr 1999; 129:1656-1661
5. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-176
6. Agius E, Attard G, Shakespeare L, Clark P, Vidya MA, Hattersley AT, et. al. Familial factors in diabetic nephropathy: an offspring study. Diabet Med 2006;23:331-334
7. Ksiazek P, Bednarek-Skublewska A, Buraczynska M. The C677T methylenetetrahydro-folate reductase gene mutation and nephropathy in type 2 diabetes mellitus. Med Sci Monit 2004;10: BR47-51.
8. Mtiraoui N, Ezzidi I, Chaieb M, Marmouche H, Aouni Z, Chaieb A, et. al. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract 2007;75: 99-106.
9. Noiri E, Taguchi J, Nakao A, Fujita T. MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients. Diabetes Care 2000;23:260.
10. Zintzaras E, Uhlig K, Koukoulis GN, Papathanasiou AA, Stefanidis I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet 2007;52:881-890
11. Shpichinetsky V, Raz I, Friedlander Y, Goldschmidt N, Wexler ID, Ben-Yehuda A, et. al. The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. J Nutr 2000;130:2493-2497
12. Yoshioka K, Yoshida T, Umekawa T, Kogure A, Takakura Y, Toda H, et. al. Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese type 2 diabetic patients. Diabet Med 2004;21:1051-1052
13. Moczulski D, Fojcik H, Zukowska-Szczechowska E, Szydlowska I, Grzeszczak W. Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transplant 2003;18:1535-1540
14. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet 2004;20:439-444
15. Zintzaras E, Lau, J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 2008; 61:634-645
16. Eroglu Z, Erdogan M, Tetik A, Karadeniz M, Cetinalp S, Kosova B, et. al. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy. Diabetes Metab Res Rev 2007;23:621-624
17. Odawara M, Yamashita K, Yamada N. MTHFR gene variant is not associated with diabetic nephropathy in Japanese. Nucleic Acids Symp Ser 1999;42:85-86
18. Ameen G, Irani-Hakime N, Fawaz NA, Mahjoub T, Almawi WY. An Arab selective gradient in the distribution of factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T. J Thromb Haemost 2005;9:2126-2127
19. Böger CA, Stubanus M, Haak T, Götz AK, Christ J, Hoffmann U, et. al. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. Nephrol Dial Transplant 2007;22:154-162
20. Castro R, Rivera I, Ravasco P, Jakobs C, Blom HJ, Camilo ME, et. al. 5,10-Methylenetetrahydrofolate reductase 677C™T and 1298A™C mutations are genetic determinants of elevated homocysteine. QJM 2003;96:297-303.
21. Bennouar N, Allami A, Azeddoug H, Bendris A, Laraqui A, El Jaffali A, et. al. Thermolabile methylenetetrahydrofolate reductase C677T polymorphism and homocysteine are risk factors for coronary artery disease in Moroccan population. J Biomed Biotechnol 2007;1:80687.
22. Mazza A, Bossone E, Mazza F, Distante A. Reduced serum homocysteine levels in type 2 diabetes. Nutr Metab Cardiovasc Dis 2005;15:118-124